-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
OnKure Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2024.
- OnKure Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2025 was -$16.3M, a 13.8% decline year-over-year.
- OnKure Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2025 was -$63.5M, a 165% decline year-over-year.
- OnKure Therapeutics, Inc. annual Operating Income (Loss) for 2024 was -$54.4M, a 47.3% decline from 2023.
- OnKure Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$36.9M, a 31.4% increase from 2022.
- OnKure Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$53.8M, a 35.2% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)